logo
  • Home
  • News
Menu

The Valens Posts C$12.8M Loss in Q3

Home / Stock Analysis / The Valens Posts C$12.8M Loss in Q3
Article feature image

The Valens Posts C$12.8M Loss in Q3

14 Oct Stock Analysis

The Valens (VLNS) posted a rise in sales in the third quarter of 2021, but a wider loss than in the third quarter of 2020. The British Columbia-based company produces medical and recreational cannabis products.
Net revenues came in at C$21 million in the…

Click here to view the original article.

Tags:
Global, Yahoo Entertainment
Facebook Google+ Twitter Pinterest
  Previous
Next  

Related Posts

1585186568557.jpeg
+

A Fresh Look at American Superconductor (AMSC) Valuation After Recent Share Price Momentum

11 Oct Stock Analysis
1585186599552.jpeg
+

Protagonist Therapeutics, Inc.’s (NASDAQ:PTGX) 51% Price Boost Is Out Of Tune With Revenues

11 Oct Stock Analysis

recent post

  • 1585186568557.jpeg

    A Fresh Look at American Superconductor

    Oct 11 2025
  • CRYPTO-LIQUIDATIONS-TRUMP-CHINE.png

    Here are the details of a

    Oct 11 2025
  • portobello-valida-su-estrategia-de-inversion-con-la-venta-a-fremman-de-su-participacion-en-agq-labs.jpeg

    Portobello validates investment strategy by selling

    Oct 11 2025
  • 1585186599552.jpeg

    Protagonist Therapeutics, Inc.’s (NASDAQ:PTGX) 51% Price

    Oct 11 2025
  • gold.jpg

    Gold-Backed Tokens Remain Stable Amid $19B

    Oct 11 2025

Categories

  • Business
  • Crypto News
  • Investing Strategy
  • People
  • Stock Analysis

©2019.  All Rights Reserved.